All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Study Links Lithium Deficiency to Alzheimer’s Disease, Suggests New Treatment Approach

By

highfrequency

9mo ago· 7 min readenNews

Summary

A new study suggests that lithium deficiency could be a cause of Alzheimer’s disease, offering a potential therapeutic approach. Researchers found that lithium compounds can reverse disease symptoms in mice, raising hopes for broader treatment options beyond targeting amyloid beta or tau proteins.

Key quotes

· 3 pulled
“The idea that lithium deficiency could be a cause of Alzheimer’s disease is new and suggests a different therapeutic approach.”
“The study raises hopes that researchers could one day use lithium to treat the disease in its entirety rather than focusing on a single facet such as amyloid beta or tau.”
“One of the main discoveries in the study is that as amyloid beta begins to form, lithium loss occurs.”
Snippet from the RSS feed
Study: Lithium loss ignites Alzheimer’s, but lithium compound can reverse disease in mice

You might also wanna read

Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida

Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to

bit.ly·1h ago

Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1

Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus

biozentrum.unibas.ch·1h ago

Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation

A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.

bbc.co.uk·5h ago

Exploring the science behind quantum effects in healthcare: separating research from pseudoscience

The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg

newscientist.com·6h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·6h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·6h ago